Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 4, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 September 2026 - 14:20

Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 4, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tyruko

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters